Page last updated: 2024-08-23

paroxetine and Hypothermia

paroxetine has been researched along with Hypothermia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (45.45)18.2507
2000's6 (54.55)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosch, A; Del Castillo, JC; Del Río, J; Heras, B; Lasheras, B; Martínez-Esparza, J; Monge, A; Mourelle, M; Oficialdegui, AM; Orús, L; Palop, JA; Pérez-Silanes, S; Roca, J; Tordera, R1
Bull, EJ; Fone, KC; Hutson, PH1
Camarasa, J; Escubedo, E; Farré, A; Fisas, MA1
Al Chekakie, MO; Ketz, JM; Whinney, CM1
Cowen, PJ; Odontiadis, J; Pearson, G; Sargent, P; Williamson, DJ1
Cryan, JF; Leonard, BE; McGrath, C; Norman, TR2
Baker, GB; Bourin, M; Colombel, MC; Redrobe, JP1
Aguirre, N; Barrionuevo, M; Del Río, J; Lasheras, B; Ramírez, MJ1
Aguirre, N; Hervías, I; Lasheras, B1
Middlemiss, DN; Price, GW; Roberts, C; Watson, J1

Reviews

1 review(s) available for paroxetine and Hypothermia

ArticleYear
SB-236057-A: a selective 5-HT1B receptor inverse agonist.
    CNS drug reviews, 2001,Winter, Volume: 7, Issue:4

    Topics: Animals; Autoreceptors; Brain; Cyclic AMP; Humans; Hypothermia; Indoles; Microdialysis; Paroxetine; Pyridines; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

2001

Trials

1 trial(s) available for paroxetine and Hypothermia

ArticleYear
Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
    Psychopharmacology, 1997, Volume: 132, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Double-Blind Method; Humans; Hydrocortisone; Hypothermia; Male; Middle Aged; Paroxetine; Piperazines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Triazoles

1997

Other Studies

9 other study(ies) available for paroxetine and Hypothermia

ArticleYear
New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Journal of medicinal chemistry, 2001, Feb-01, Volume: 44, Issue:3

    Topics: Animals; Antidepressive Agents; Avoidance Learning; Carrier Proteins; Colony-Forming Units Assay; Conditioning, Operant; Cyclic AMP; HeLa Cells; Humans; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Piperazines; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thiophenes

2001
Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
    Neuropharmacology, 2003, Volume: 44, Issue:4

    Topics: Animals; Brain; Corticosterone; Exploratory Behavior; Hydroxyindoleacetic Acid; Hypothermia; In Vitro Techniques; Male; Maze Learning; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperazines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Substance Withdrawal Syndrome

2003
Effects of lesopitron on the central nervous system arising from its interaction with 5-HT1A receptors.
    Pharmacology, 2004, Volume: 72, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Catalepsy; Central Nervous System; Central Nervous System Depressants; Drug Interactions; Female; Hippocampus; Hypothermia; In Vitro Techniques; Ligands; Male; Mice; Paroxetine; Piperazines; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Species Specificity

2004
Hypothermia in a patient receiving risperidone and paroxetine.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:3

    Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dementia; Female; Humans; Hypothermia; Paroxetine; Risperidone

2006
Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?
    European journal of pharmacology, 1998, Jul-03, Volume: 352, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Therapy, Combination; Exploratory Behavior; Hypothermia; Male; Olfactory Bulb; Paroxetine; Pindolol; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists

1998
Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Journal of psychopharmacology (Oxford, England), 1998, Volume: 12, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amines; Animals; Antidepressive Agents; Apomorphine; Brain; Clonidine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Hypothermia; Indoles; Male; Mice; Motor Activity; Norepinephrine; Paroxetine; Pindolol; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming

1998
Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
    Pharmacology, biochemistry, and behavior, 1999, Volume: 63, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Depression; Disease Models, Animal; Drug Synergism; Exploratory Behavior; Hypothermia; Male; Motor Activity; Olfactory Bulb; Paroxetine; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists

1999
Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.
    Neuroreport, 1999, Nov-26, Volume: 10, Issue:17

    Topics: Animals; Antioxidants; Astrocytes; Binding Sites; Carrier Proteins; Fever; Frontal Lobe; Glial Fibrillary Acidic Protein; Hippocampus; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nerve Tissue Proteins; Neuroprotective Agents; Paroxetine; Pyramidal Cells; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins; Thioctic Acid

1999
2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
    Journal of neurochemistry, 2000, Volume: 75, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Body Temperature; Brain; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Frontal Lobe; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxins; Niacinamide; Organ Specificity; Paroxetine; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins

2000